KemPharm is a clinical-stage pharmaceutical company that uses its innovative LAT platform technology to discover and develop prodrugs, with the goal of treating serious medical conditions. Its drug development focuses on improving efficacy and safety, thereby meeting critical unmet medical needs. KemPharm's goal is to make significant contributions to patient care through the development of new and effective therapies.